Table 3.
Summary of the effects of intra-mPFC R-CPP in combinations with 5-HT1A, 5-HT2A, and 5-HT2C agents, an mGlu2/3 agonist and various antipsychotics on attention and executive control and glutamate (GLU) and serotonin (5-HT) release in the mPFC.
| Attention | Impulsivity | Compulsivity | GLU | 5-HT | |
|---|---|---|---|---|---|
| R-CPPa,b | ↓ | ↑ | ↑ | ↑ | ↑ |
| SEROTONIN AGENTS | |||||
| + 8-OH-DPATc,d | 0 | ↑ | 0 | 0 | 0 |
| + M100907a,c,d | 0 | 0 | ↑ | 0 | 0 |
| + Ro60-0175e | 0 | 0 | ↑ | 0 | 0 |
| mGlu2/3 AGENTS | |||||
| + LY379268f | 0 | 0 | ↑ | 0 | nd |
| ANTIPSYCHOTICS | |||||
| + haloperidolg,h | ↓ | 0 | 0 | ↑ | 0 |
| + aripiprazoleh | 0 | ↑ | 0 | 0 | 0 |
| + olanzapineh | 0 | 0 | ↑ | 0 | 0 |
| + clozapinei | 0 | 0 | ↑ | 0 | 0 |
| + sertindolei (0.32 mg/kg) | 0 | ↑ | ↑ | 0 | 0 |
| + sertindolei (2.5 mg/kg) | ↓ | ↑ | ↑ | ↑ | ↑ |